Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
This non-interventional study is to monitor use in real practice in Korea including adverse events on Aromasin (Exemestane).
All cases at the participating institutions.
Inclusion Criteria:
Exclusion Criteria:
Goyang-si, Gyeonggi-do 412-270, South Korea
Iksan -si, Jeollabuk-do 570-749, South Korea
Cheonnam, South Jeolla Province 519-809, South Korea
Seoul, 120-752, South Korea